Ulcerative colitis has several available treatments, including one from Pfizer. FDA approval of a new drug gives Pfizer an opportunity to expand its reach in this market with a molecule whose ...

New data suggest more is better, but choices come with tradeoffs ...

Merck & Co Inc. MRK on Monday said its investigational therapy tulisokibart achieved the primary endpoint in a Phase 3 study in moderately to severely active ulcerative colitis (UC), marking what the ...

Ulcerative colitis (UC) is an inflammatory bowel disease that causes irritation, inflammation, and ulcers in the tissues lining the large intestine. Known to be a long-term condition, UC can result in ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 ATLAS-UC induction-only study (Study 2) evaluating tulisokibart ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Medications for ulcerative colitis (UC) can treat and prevent flares, but they can also come with some uncomfortable side effects. For example, immunomodulators like azathioprine (Azasan) decrease UC ...

Your doctor has told you you have ulcerative colitis (UC), and now you’re learning about the treatment options and lifestyle tweaks that can support your new diagnosis. Along with this medical ...

When you have ulcerative colitis (UC), monitoring your symptoms, diet, exercise, medication, and personal well-being is vital. Smartphone tracking apps can help. “The information these tracking apps ...

Ulcerative colitis (UC) is a chronic disease that causes inflammation and sores in the lining of your colon. It’s a complicated disease that can interfere with your quality of life. You may miss days ...